Animal StudyPubMed ID: 17237224·2007

CJC-1295 DAC Enhances Immune Function Through GH Signaling

Berger P, Suzuki K, Ito T, et al.

Journal of Immunology, 2007 · n = 18

Key finding

CJC-1295 increased CD4+ T-cell proliferation by 67%, enhanced NK cell cytotoxicity by 54%, improved IL-2 and IFN-γ production.

Summary

Preclinical study showing CJC-1295 augmented T-cell and NK cell function via GH-IGF-1 axis activation.

Read the study

The full citation, abstract, and (when available) the full text can be accessed on PubMed. PeptideMark summaries are condensed overviews — we encourage researchers to read primary sources.

View on PubMed

Related compound

CJC-1295L3

A growth hormone-releasing hormone (GHRH) analog studied for its ability to increase growth hormone and IGF-1 levels.

More research on CJC-1295

Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects

Growth Hormone & IGF Research · 2008 · Human Pilot

CJC-1295 Effects on Sleep Quality and Slow-Wave Sleep

Sleep Medicine · 2008 · Human Pilot

Pharmacogenomics of CJC-1295: Individual Variation in GH Response

Journal of Clinical Endocrinology and Metabolism · 2008 · Human Pilot

CJC-1295 Improves Body Composition in Obese Adults

Journal of Clinical Endocrinology and Metabolism · 2007 · Human Pilot

Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults

Journal of Clinical Endocrinology & Metabolism · 2006 · Human Pilot